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Detection of CD44+ cancer initiating cells in pleural effusion of a liver cancer patient
AK Chow1, RT Poon1,2, R Ng1, L Chiu1, S Chan1, R Pang3
1Centre for Cancer Research, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
2Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
3Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
introduction: Advanced hepatocellular carcinoma (HCC) is always accompanied with multiple lung metastasis which 
may result in an accumulation of fluid in the pleura. Recently, the concept of cancer-initiating cells in HCC has been 
established. By studying the cells isolated from the pleural effusion (PE) may provide a model to study the presence 
of cancer-initiating cells which lead to metastatic disease in HCC. The objective of this case study was to detect a 
subpopulation of CD44+ cancer-initiating cells in PE.
Methods: PE-derived cells were isolated from PE using ficoll density gradient and primary culture was sustained in 
DMEM with 30% v/v sterilely filtered PE-fluid to provide the microenvironment for the growth of the isolated cells. 
Flow cytometry was performed to detect the amount of CD44+ subpopulation. CD44+ and CD44– cells were then 
isolated by fluorescent-activated cell sorting (FACS) and spheres formation was performed using 1000 cells/well on 
an ultra-low attachment plate. CD44+ cells were also subjected to differentiate into osteocytes using the StemPro 
osteogenesis differentiation kit. PCR analysis was performed to detect the stem cell and liver cell marker of the CD44+ 
subpopulation. 
Results: Flow cytometry analysis demonstrated that over 90% of the cells isolated were CD44+ cells. PE-derived cells 
were able to be expanded in culture for several weeks. CD44+ but not CD44– cells were able to form spheres in vitro. 
CD44+ cells were also able to be differentiated into osteocytes with positive staining of calcium accumulation using 
Alizarin Red S staining. PCR analysis demonstrated the expression of markers for stem cell (Lin28, Oct4, Nanog, Sox2 
and Msi1) and liver cell (alpha-fetoprotein, albumin and asiaglycoprotein receptor). 
Conclusion: This is a case study demonstrating the presence of cancer-initiating cells in PE by detection of CD44+ cells. 
The isolation of PE-derived cells might provide a model for subsequent molecular and cellular analyses, which allows 
the study of cancer-initiating cells in metastatic HCC patients and provides a direction for the preclinical development 
of rational therapeutics. 
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Plasma pigment epithelium-derived factor as a mediator of insulin resistance associated with  
estrogen deficiency
WS Chow1, MAM Yuen1, C Cheng2, TC Pun3, LSC Law2, AWK Tso1,2, A Xu2, KSL Lam1,2
1Department of Medicine, Queen Mary Hospital, Hong Kong
2Faculty of Medicine, The University of Hong Kong, Hong Kong 
3Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong
Objective: Pigment epithelium-derived factor (PEDF), a serine protease inhibitor secreted from adipose tissue and 
present at high concentrations in the circulation, has been found in mice to play a pathogenic role in obesity-induced 
insulin resistance and metabolic dysfunctions. Serum PEDF levels are lower in women and treatment of cultured 
human ovarian surface epithelial cells with 17β-estradiol inhibited the expression of PEDF at a transcriptional level. 
To further delineate the relationship between estrogen and PEDF, we investigated the change in PEDF levels in pre-
menopausal women following bilateral salpingo-oophorectomy (BSO). 
Methods: We measured body mass index (BMI), waist circumference (WC), percentage body fat, plasma PEDF and 
estradiol levels in a group of pre-menopausal women before and after BSO for benign gynaecological conditions. 
Repeated measure ANOVA was used to analyse the changes (∆) in PEDF, estradiol, homeostatic model assessment of 
insulin resistance (HOMA-IR) and quantitative insulin-sensitivity check index (QUICKI) following BSO. 
Results: Twenty-one pre-menopausal women (age, 49.57±3.54 years) were recruited. The mean duration between 
pre- and post-operative assessment was 4.01±0.72 months. BMI was marginally reduced in the postoperative period 
(25.24±3.98 kg/m2 preop vs 24.80±4.34; P=0.048). However, no significant difference between WC or percentage 
body fat was observed. The marked reduction in plasma estradiol levels postoperatively (225 [109-418] pmol/L preop 
vs 32 [19-50]; P<0.001) was accompanied by an increase in plasma PEDF levels (7.66±1.61 ng/mL preop vs 8.77±1.53; 
P=0.001, after controlling for change in BMI). An inverse relationship was found between ∆estradiol and ∆PEDF (r= 
–0.497; P=0.022). There was also a significant increase in insulin resistance postoperatively, as indicated by HOMA-
IR (1.06 [0.73-1.93] preop vs 1.63 [1.06-2.26]; P=0.002) and QUICKI (0.38±0.04 preop vs 0.36±0.03; P=0.006). 
∆HOMA-IR and ∆QUICKI became insignificant (P=0.101 and 0.141 respectively) after adjusting for ∆PEDF. 
Conclusions: We have demonstrated that the reduction in plasma estradiol levels after BSO was significantly 
associated with an increase in plasma PEDF levels and insulin resistance in a group of pre-menopausal women. The 
loss of statistical significance in ∆HOMA-IR and ∆QUICKI after adjusting for ∆PEDF suggests that PEDF may play a 
role in mediating insulin resistance in these women with surgical menopause, and its expression is likely regulated by 
estradiol, as evidenced by the correlation between ∆estradiol and ∆PEDF.
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